Grossi Federico 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 9, 2023
Insider Transaction Report
Form 4
Grossi Federico
See Remarks
Transactions
- Sale
Common Stock
2023-01-05$48.79/sh−2,500$121,975→ 94,884 total
Footnotes (1)
- [F1]This is a scheduled sale from 10b5-1 trading plan.